

NOT ONLY DIABETES AND OBESITY! The Potential Cancer-Preventive Effects Expected from GLP-1 Receptor Agonists
Masahiro Kami, M.D., Ph.D. President, Medical Governance Research Institute, Tokyo, Japan Table of Contents Lowering Blood Glucose and Reducing Body Weight GLP-1 Drugs Suppress Chronic Inflammation and Reduce Cancer Risk Obesity-Related Cancer Risk Reduced by 40% Through Factors Beyond Weight Loss Diet and Exercise Therapy Are Important, But… I would like to write once again about GLP-1 receptor agonists—the drugs that have been in the spotlight as so-called “weight-loss dr
11 hours ago




















